drugset
drugset / Trial / NCT04313205

A Pharmacokinetic Study of JKB-122 Tablets Compared to Capsule

NCT04313205 ↗

Phase 1 Unknown 8 enrolled TaiwanJ Pharmaceuticals Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the pharmacokinetics of JKB-122 tablets with JKB-122 capsules in healthy male subjects subjects.

Timeline

Start
2020-08
Primary completion
2020-12
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator JKB-122 Unknown — —

Indications

autoimmune hepatitis